Putting together the findings of a lack of predictive power of insulin use on the mortality from lung cancer in our recent prospective 12-year follow-up study [31] and the lack of an association with the incidence of lung cancer in the present study (Table 2), the lung may also be one of those less sensitive organs. This evidence concerns the gene INS and lung carcinoma.